CDKN2A and melanoma: Increased p16 results in decreased retinoblastoma (Rb) protein phosphorylation preventing cell cycle progression from G1 to S.18, 19 p16 expression is lost in a variety of malignancies including bladder, pancreatic, colorectal, and lung carcinomas and melanomas.18, 19